Skip to content

Enviomycin

C25H43N13O10 — CID 25202236

💊View drug profile → enviomycin

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
SMILESNCC[C@@H](O)[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2CCN=C(N)N2)NC(=O)C(=CNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O
InChIInChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/t10-,11-,12+,14+,15+,16-,18+/m1/s1
InChIKeyHPWIIERXAFODPP-MYIPQGGFSA-N
MW685.70 g/mol
LogP-9.23
Rot. Bonds10

About Enviomycin

Enviomycin (PubChem CID 25202236) has the molecular formula C25H43N13O10 and a molecular weight of 685.70 g/mol. Its IUPAC name is (3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide.

Molecular Properties

Compound NameEnviomycin
PubChem CID25202236
Molecular FormulaC25H43N13O10
Molecular Weight685.70 g/mol
Exact Mass685.33
IUPAC Name(3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
SMILESNCC[C@@H](O)[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2CCN=C(N)N2)NC(=O)C(=CNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O
InChIInChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/t10-,11-,12+,14+,15+,16-,18+/m1/s1
InChIKeyHPWIIERXAFODPP-MYIPQGGFSA-N
XLogP-9.23
TPSA392.86 Ų
H-Bond Donors15
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms48
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500685.70
LogP ≤ 5-9.23
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze Enviomycin with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of Enviomycin?
The IUPAC name of Enviomycin (CID 25202236) is (3R,4R)-3,6-diamino-N-[(3S,9S,12S,15S)-3-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide.
What is the SMILES notation for Enviomycin?
The canonical SMILES for Enviomycin is NCC[C@@H](O)[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2CCN=C(N)N2)NC(=O)C(=CNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O.
What is the InChIKey of Enviomycin?
The InChIKey is HPWIIERXAFODPP-MYIPQGGFSA-N. The full InChI is InChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/t10-,11-,12+,14+,15+,16-,18+/m1/s1.
What are the key properties of Enviomycin?
Enviomycin has a molecular weight of 685.70 g/mol, XLogP of -9.23, 10 rotatable bonds, 15 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for Enviomycin is sourced from PubChem (CID 25202236), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules: E · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.